Trial Profile
A Four-period, Randomised, Open-label, Crossover, Pharmacokinetic Study to Assess the Dose Proportionality and Relative Bioavailability of Buprenorphine Transdermal Delivery System Second Generation Patches Compared to First Generation Patches, in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Oct 2014
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors Mundipharma Research
- 29 Sep 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 17 Jun 2014 New trial record